Q2 2023

Filed Aug 11, 2023 · 10-Q · 42 days after period end · 0001493152-23-027838

Q2 2023 · 10-Q

Revenue

$13.16K

−56.7% vs Q2 2022

Net Income

-$3.05M

N/M vs Q2 2022

EPS Diluted

-$1.51

N/M vs Q2 2022

Operating Income-$3,109,318N/M

Operating Cash Flow

Same quarter

Metric	Q2 2023	Q2 2022	Q2 2021	Q2 2020
Revenue	$13.16K	$30.39K	—	—
Net Income	-$3.05M	-$3.59M	-$3.82M	-$12.34M
EPS Diluted	-$1.51	-$1.85	-$0.03	-$0.24

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Oragenics Inc · CIK 1174940 · Engraved from SEC EDGAR